|
ZVSA Zyversa Therapeutics Inc 1859007 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-1,793,381.00 |
| Balance Sheet |
|
Current Assets
|
$742,223.00 |
|
Assets
|
$742,223.00 |
|
Current Liabilities
|
$14,866,518.00 |
|
Liabilities
|
$14,866,518.00 |
|
Equity
|
$-14,124,295.00 |
|
Shares Out
|
8095921.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-799,118.00 |
| Market Analysis |
Market Cap
|
$890,551.31 |
|
Price
|
$0.10 |
|
PB
|
0.77 |
|
EPS
|
-0.22 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:48 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:49 |
|
| Apr |
May |
Jun |
| 2026-03-31 |
-4.18 |
|
|
2026-05-13 |
-0.22 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-13 |
-0.46 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-19 |
-2.56 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ZVSA documents filed with the SEC.
ZVSA Filings
Clear
